300 likes | 461 Views
2010. HIV/AIDS surveillance in Europe. European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen. HIV/AIDS surveillance.
E N D
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen
HIV/AIDS surveillance • Describes the HIV epidemic and its characteristics, and identifies population groups at risk and in need for targeted prevention measures. • Monitors trends in HIV/AIDS over time in order to assess the situation and compare trends across Europe. • Improves and harmonises European HIV/AIDS surveillance methods and catalyses national efforts to improve HIV/AIDS surveillance. • Supplies relevant data for evidence-based public health policies.
HIV/AIDS surveillance in EuropeFramework for data collection As from 2008, ECDC and the WHO Regional Office for Europe jointly coordinate HIV/AIDS surveillance in 54 countries. A sustainable surveillance system is crucial when informing about prevention efforts and healthcare planning. ECDC WHO/Europe Competent Bodies for surveillance WHO EURO = 'Competent Body' for non-EU/EEA countries Provide EU/EEA HIV national contact point nomination Provides non-EU/EEA HIV national contact point nomination HIV contact points nominated Data sent to the joint HIV/AIDS database hosted by ECDC Data validation performed by ECDC Full access to the HIV/AIDS validated data ECDC HIV experts WHO/Europe HIV experts HIV national contact points
HIV infections diagnosed in 2010,WHO European Region and EU/EEA • No data from Austria, Liechtenstein • ** Excludes individuals originating from countries with generalised epidemics. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed, 2010All cases, EU/EEA < 2 2 to < 10 10 to < 20 ≥ 20 Missing or excluded data Rate as number per 100 000 population Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed, 2010Men who have sex with men, EU/EEA < 1 1 to < 3 3 to < 5 ≥ 5 Missing or excluded data Rate as number per 100 000 male population Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed, 2010Injecting Drug Use, EU/EEA < 0.2 0.2 to < 1 1 to < 3 ≥ 3 Missing or excluded data Rate as number per 100 000 population Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed 1984–2010, EU/EEA Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infection by transmission group and origin in EU/EEA, 2004–10 Predominant transmission group: men who have sex with men Data were not included or not available from Austria, Estonia and Poland. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
Heterosexually acquired HIV infections Proportion of cases among persons originating from countries with generalised epidemics, 2010 Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
Conclusions • HIV infection is of major public health importance in Europe, with evidence of continuing transmission and no clear signs of decrease. • Large heterogeneity exists in HIV epidemics in the EU/EEA: • Predominant mode of transmission is sex between men. • Considerable proportion among heterosexually acquired cases comes from countries with a generalised epidemic. • Continued HIV transmission among IDUs in eastern EU countries.
HIV infections diagnosed in 2010 per 100 000 population: all cases Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed in 2010 per 100 000 male population: men who have sex with men Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed in 2010 per 100 000 population: injecting drug users Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections diagnosed in 2010 per 100 000 population: heterosexual cases Excludes persons from countries with generalised epidemics. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
Geographical areas: WHO European Region West East Centre
HIV infections diagnosed in 2010 WHO European Region *No data from the following countries: Austria, Liechtenstein, Monaco. ** Countries with no data on age or transmission mode excluded. *** Excludes individuals originating from countries with generalised epidemics. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infection in the three geographical areas and EU/EEA, WHO European Region, 2004–10 Data not reported or not available from Austria, Russia, Monaco. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections, 2004–10: transmission groups in WHO European Region, East Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
HIV infections, 2004–09: transmission groups in WHO European Region, Centre Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
AIDS diagnoses, 2004–10WHO European Region Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2010
Distribution of three most common AIDS indicative diseases by transmission group, WHO European Region, 2010 *pulmonary in adults and adolescents
Limitations of data • Coverage: • Data from a number of countries is not reported to TESSy and for several others reported at sub-national level. • Reporting and testing: • Reporting systems may differ across countries; • Testing patterns may have changed over time. • Data quality • Completeness is insufficient for several variables; • Under-reporting, reporting delays influence interpretation of recent trends.
Conclusions (1) • HIV infection is a disease of major public health importance in Europe, with evidence of continuing HIV transmission in European countries. • Overall, the number of diagnosed cases of HIV infection has shown no clear sign of decrease, while AIDS diagnoses continue to decline in the WHO European Region, except in several Eastern and Central European countries.
Conclusions (2) • Heterosexual transmission: • increasing in many countries in the East; • in the West, a considerable proportion are individuals originating from countries with generalised epidemic. • Transmission among injecting drug users: • continuing transmission in many countries in the East; • low-level epidemic in the West and Centre. • Transmission among men who have sex with men: • increasing and predominant epidemic in many countries in the West; • increasing transmission in Central Europe.
The full report is available from: www.ecdc.europa.eu 2010